HOLMLUND JON T 4
4 · Galera Therapeutics, Inc. · Filed Sep 3, 2021
Insider Transaction Report
Form 4
HOLMLUND JON T
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option
2021-09-01−47,756→ 61,142 totalExercise: $2.43Exp: 2026-03-31→ Common Stock (47,756 underlying) - Sale
Common Stock
2021-09-01$8.47/sh−47,756$404,498→ 0 total - Exercise/Conversion
Common Stock
2021-09-01$2.43/sh+47,756$116,047→ 47,756 total
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.11 to $9.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option has fully vested and is currently exercisable.